Processa Pharmaceuticals (PCSA) Accumulated Depreciation (2017 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Accumulated Depreciation came in at $29067.0 in Q4 2021, up 1.69% YoY from $28583.0 in Q4 2020, and little changed on a QoQ basis from $29067.0 in Q3 2021.
Processa Pharmaceuticals (PCSA) Accumulated Depreciation (2017 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 5 years of Accumulated Depreciation data on file, last reported at $29067.0 in Q4 2021.
- Quarterly Accumulated Depreciation rose 1.69% year-over-year to $29067.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $29067.0 (up 1.69% YoY) and the FY2021 annual result came in at $29067.0, up 1.69% from the prior year.
- Accumulated Depreciation steadied at $29067.0 in Q4 2021, from $29067.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $29067.0 in Q1 2021 to a low of $3246.0 in Q4 2017.
- A 5-year average of $19474.3 and a median of $20137.0 in 2019 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2018 — Accumulated Depreciation jumped 260.2% — and 2021, when it increased 1.69%.
- Tracing PCSA's Accumulated Depreciation over 5 years: stood at $3246.0 in 2017, then jumped by 260.2% to $11692.0 in 2018, then soared by 72.23% to $20137.0 in 2019, then surged by 41.94% to $28583.0 in 2020, then increased by 1.69% to $29067.0 in 2021.
- The last three Accumulated Depreciation figures came in at $29067.0 (Q4 2021), $29067.0 (Q3 2021), and $29067.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 29,067.00 |
| Sep 30, 2021 | 29,067.00 |
| Jun 30, 2021 | 29,067.00 |
| Mar 31, 2021 | 29,067.00 |
| Dec 31, 2020 | 28,583.00 |
| Mar 31, 2020 | 22,249.00 |
| Dec 31, 2019 | 20,137.00 |
| Sep 30, 2019 | 18,026.00 |
| Jun 30, 2019 | 15,915.00 |
| Dec 31, 2018 | 11,692.00 |
| Sep 30, 2018 | 9,581.00 |
| Jun 30, 2018 | 7,469.00 |
| Dec 31, 2017 | 3,246.00 |